小分子RNA配体:一个专利审查 (2018-2024)
Elia Ravegnini1, Andrea Trabocchi1, Elena Lenci1
1Department of Chemistry "Ugo Schiff", University of Florence, Florence, Italy.
Expert opinion on therapeutic patents
|April 12, 2025
概括
针对RNA结构的小分子为现有疗法提供了一个有希望的替代方案,在癌症和传染病中具有广泛的应用. 最近的专利突显了这些RNA配体的日益兴趣和潜力.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 在RNA治疗方面,RNA疗法.
背景情况:
- 针对三维RNA结构的小分子正在作为一个可行的治疗策略获得引力.
- 这些分子提供了口服生物可用性和可调性特性等优势,为反感性寡核酸 (ASO) 和小干扰RNA (siRNA) 提供了替代品.
- 由于RNA参与了许多生理和病理过程,因此可用于各种治疗领域,从瘤学到传染病和神经系统疾病.
研究的目的:
- 审查2018年1月至2024年10月期间发布的小分子RNA配体专利.
- 评估目前RNA向小分子药物开发的现状和新兴趋势.
主要方法:
- 使用 Espacenet,Patentscope 和 Google 专利数据库进行全面的专利搜索.
- 包括标准集中在与结合RNA结构的小分子相关的专利上.
- 专利搜索的时间表:2018年1月-2024年10月.
主要成果:
- 专利申请的显著增加表明了RNA向策略的重要性日益增加.
- 该领域仍在发展,在实现目标选择性方面存在挑战.
- RIBOTAC衍生物代表了针对性RNA降解的新兴方法,可能减少副作用.
结论:
- 专利格局表明,人们对小分子RNA连接体有着强烈且日益增长的兴趣,用于治疗开发.
- 需要进一步的研究来解决选择性挑战和优化药物设计.
- 像RIBOTACs这样的创新方法显示出增强治疗疗效和安全的希望.
更多相关视频
14:15Highly Efficient Ligation of Small RNA Molecules for MicroRNA Quantitation by High-Throughput Sequencing
Published on: November 18, 2014
11.8K
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
9.4K
相关概念视频
02:30siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
01:56Riboswitches
8.0K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.0K
01:23Types of RNA
62.8K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
62.8K
01:23RNA Interference
25.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.8K
01:53RNA Stability
33.1K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.1K
02:40Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K